|
CMPS
|
COMPASS Pathways Plc
|
US
|
NASDAQ
|
|
CPRX
|
Catalyst Pharmaceutical Partners, Inc.
|
US
|
NASDAQ
|
|
CRXT
|
Clarus Therapeutics Holdings, Inc.
|
US
|
NASDAQ
|
|
DICE
|
DICE Therapeutics, Inc.
|
US
|
NASDAQ
|
|
DSEY
|
Diversey Holdings, Ltd.
|
US
|
NASDAQ
|
|
EHAB
|
Enhabit, Inc.
|
US
|
NYSE
|
|
ELDN
|
Eledon Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
ELEV
|
Elevation Oncology, Inc.
|
US
|
NASDAQ
|
|
ENSC
|
Ensysce Biosciences, Inc.
|
US
|
NASDAQ
|
|
EVO
|
Evotec SE
|
US
|
NASDAQ
|
|
EXAI
|
Exscientia Limited
|
US
|
NASDAQ
|
|
FWBI
|
First Wave BioPharma, Inc.
|
US
|
NASDAQ
|
|
GDRX
|
GoodRx Holdings, Inc.
|
US
|
NASDAQ
|
|
GHSI
|
Guardion Health Sciences, Inc.
|
US
|
NASDAQ
|
|
GRCL
|
Gracell Biotechnologies Inc.
|
US
|
NASDAQ
|
|
HITI
|
High Tide Inc.
|
US
|
NASDAQ
|
|
HOWL
|
Werewolf Therapeutics, Inc.
|
US
|
NASDAQ
|
|
HSAQ
|
Health Sciences Acquisitions Corporation 2
|
US
|
NASDAQ
|
|
HUGE
|
FSD Pharma Inc. - Class B Subordinate Voting Shares
|
US
|
NASDAQ
|
|
HUMA
|
Humacyte, Inc.
|
US
|
NASDAQ
|